Overview
Finland X-ray detector provider's Q1 2026 revenue grew 13.5% yr/yr
Q1 2026 EPS rose to EUR 0.13 from EUR 0.05
Company expects net sales to grow yr/yr in Q2 and Q3, but notes uncertainty
Outlook
Detection Technology expects net sales to grow year-on-year in Q2 and Q3 2026
Company aims for at least 10% annual sales growth and 15% operating margin in medium term
Company says geopolitical risks, U.S. tariffs, and price competition in China create uncertainty
Result Drivers
BROAD-BASED GROWTH - Co said net sales grew across all business applications and regions, with strong performance in medical, security, and industrial segments
EASED MATERIAL SHORTAGES - Co said material shortages that hindered deliveries last year have eased due to proactive measures
NEW PRODUCTS - Launch of AIDA detector system and X-ACE HS product family contributed to portfolio and were well received
Company press release: ID:nWkrb562Hg
Key Details
Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
EUR 25.26 mln
Q1 EPS
EUR 0.13
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the advanced medical equipment & technology peer group is "buy"
Wall Street's median 12-month price target for Detection Technology Oyj is €12.75, about 29.8% above its April 22 closing price of €9.82
The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 14 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)